My research has centered on understanding the underlying cellular mechanisms and identifying novel treatments for neurodegenerative, neuromuscular, and inflammatory diseases. Most recently, I have been developing gene therapies for diseases that affect the eye like retinitis pigmentosa, uveitis, and age-related macular degeneration.
Earlier in my career I studied muscular dystrophies associated with mutations in dysferlin and members of the dystrophin-glycoprotein complex. While these are very different diseases from those that affect the eye, the underlying cell biology share common features. For example, inherited mutations can have a negative consequence on calcium signaling, cell membrane biology, or cytoskeletal dynamics, which ultimately cause different diseases depending on the cell type affected (i.e. muscle myofibers or retinal neurons).
You can explore highlights from my previous work below. For a complete list of my publications and abstracts, I invite you to visit my Google Scholar profile.
Keystone Symposia on Molecular & Cellular Biology: Targeting Dry Age-related Macular Degeneration 2024
Poster Presentation & Short Talk: "Suprachoroidal Delivery of a Novel Capsid Expressing a C5 Inhibitor as a Potential Treatment for Dry Age-Related Macular Degeneration"
For a complete list of publications and abstracts, please see Google Scholar.